The FDA approved six generic versions of Merck's Zocor anticholesterol drug, bringing the number of competitors with agency approval to eight. The new generics approved are made by: India's Aurobindo Pharma, Dr. Reddy's Laboratories Ltd., and Zydus Pharmaceuticals; Canada's Cobalt Pharmaceuticals; a subsidiary of Novartis AG of Switzerland; and Perrigo Co. of the U.S.

Full Story:

Related Summaries